During the development of ischemic cardiomyopathy, the activation of BAK/BAX by multiple pathways leads to cell apoptosis and necroptosis, ultimately resulting in poor prognosis and increased mortality in patients with MI/IR. The gene discussed is BAK1; the disease is ischemic cardiomyopathy.